Pleckstrin-2 as a Prognostic Factor and Mediator of Gastric Cancer Progression
Pleckstrin-2 (PLEK2) is a crucial mediator of cytoskeletal reorganization. However, the potential roles of PLEK2 in gastric cancer are still unknown. PLEK2 expression in gastric cancer was examined by western blotting and real-time PCR. Survival analysis was utilized to test the clinical impacts of...
Saved in:
| Main Authors: | Jun Wang, Zhigang He, Bo Sun, Wenhai Huang, Jianbin Xiang, Zongyou Chen, Zhenyang Li, Xiaodong Gu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/5527387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability
by: Qian Zhou, et al.
Published: (2025-07-01) -
Interferon-γ Triggers Hepatic Stellate Cell-Mediated Immune Regulation through MEK/ERK Signaling Pathway
by: Xiaodong Gu, et al.
Published: (2013-01-01) -
Endoscopic Thyroidectomy for Differentiated Thyroid Cancer
by: Yi Yang, et al.
Published: (2012-01-01) -
UBE2C-mediated ubiquitination of ACSL4 inhibits ferroptosis and promotes gastric cancer progression
by: Lei Yang, et al.
Published: (2025-08-01) -
Serum Cystatin S (CST4): A Novel Prognostic Marker for Gastric Cancer
by: Chao Gu, et al.
Published: (2025-01-01)